Strategic Acquisition Regis Technologies has joined ESTEVE CDMO, signaling expanded access to global CDMO capabilities and a broader customer base in small-molecule APIs. Leverage this integration to offer end-to-end development and manufacturing solutions across multiple regions and accelerate client onboarding.

Geographic Expansion ESTEVE CDMO operates facilities in Spain, Mexico, China, and the United States, with ongoing facility expansions in Girona Celrà Spain. This creates cross-border selling opportunities for regionalized manufacturing, supply chain resilience, and fast-track scale-up services for pharma and biotech partners.

High Potency Capabilities Recent investments in spray drying capacity and containment at Celrà and additions to the Morton Grove facility indicate a focus on high-potency small-molecule production. Target companies needing advanced containment, high-potency APIs, and scalable spray dryer operations.

Investment Momentum Significant capital activity including a $15.5M facility expansion and ongoing buildouts demonstrate growth velocity and capacity to take on larger, more complex projects. Position offerings around capacity, modernization, and reliability for growth-stage and mature programs.

Brand Consolidation Continued Regis Chromatography branding alongside ESTEVE CDMO services preserves specialized chromatography expertise within a broader CDMO platform. Present chromatography and purification capabilities as a complementary value add for API development and manufacturing programs.